Healthleap Secures $38M to Enhance AI for Identifying At-Risk Hospital Patients

Healthleap has raised $38 million, comprising an $8 million seed round co-led by Sequoia Capital and First Round Capital, followed by a $30 million Series A led by Hummingbird Ventures. Founded in 2022 in South Africa, Healthleap's AI platform identifies at-risk hospital patients by analyzing comprehensive patient data, including lab results and clinicians' notes. The company has expanded its partnerships from three to over 50 hospitals in the past year, including Penn Medicine, Cedars-Sinai, and Intermountain.

Josiah Meyer, CEO and co-founder, noted that their technology analyzes every adult inpatient's record nightly, which enables hospitals to address malnutrition, a condition affecting 20% to 50% of inpatients. Healthleap's solutions have demonstrated significant financial impacts, including an annualized savings of $23.8 million for the Hospital of the University of Pennsylvania and additional reimbursements totaling $6.3 million. Furthermore, shorter hospital stays have resulted in $17.5 million in savings.

Healthleap guarantees a minimum of 5x hard ROI, with some clients reporting over 20x annual total ROI. This funding round will support the scaling of their operations and further development of their AI capabilities, enhancing the ability of healthcare providers to monitor and manage patient risks effectively.